HD
44
4
KO
60
11
ESS
51
4
HPE
27
4
MCHP
46
4
MTB
56
4
EXPD
43
4
MMM
54
2
URI
46
3
MAC
55
12
ECL
45
3
DG
33
-3
CMA
56
6
GOOG
61
6
THC
61
6
PRU
64
4
FDX
48
7
PX
69
16
FCX
50
2
AME
54
4
HD
44
4
KO
60
11
ESS
51
4
HPE
27
4
MCHP
46
4
MTB
56
4
EXPD
43
4
MMM
54
2
URI
46
3
MAC
55
12
ECL
45
3
DG
33
-3
CMA
56
6
GOOG
61
6
THC
61
6
PRU
64
4
FDX
48
7
PX
69
16
FCX
50
2
AME
54
4
Financhill
Back

Adtran Holdings Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
46

ADTN
Adtran Holdings

Last Price:
$9.46
Seasonality Move:
9.53%
Buy
52

SRPT
Sarepta Therapeutics

Last Price:
$73.63
Seasonality Move:
14.66%
Sell
46
Adtran Holdings (ADTN) is a Sell

Is Adtran Holdings a Buy, Sell or Hold?

  • The current Adtran Holdings [ADTN] share price is $9.43. The Score for ADTN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • ADTN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $76.33. The Score for SRPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ADTN Stock Price Chart

What is Adtran Holdings's stock price today?

  • The Adtran Holdings share price today is $9.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADTN is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $76.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

ADTN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.37 Sell
Relative Strength Index (14 RSI): 46.29 Sell
Chaikin Money Flow: -663208 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.02 - 11.12) Sell
Bollinger Bands (100): (7.66 - 10.54) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.07 Sell
Relative Strength Index (14 RSI): 30.8 Sell
Chaikin Money Flow: 1304026 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (86.54 - 110.54) Sell
Bollinger Bands (100): (102.23 - 127.85) Sell

ADTN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.08 Buy
20-day SMA: 9.68 Sell
50-day SMA: 10.24 Sell
200-day SMA: 7.33 Buy
8-day EMA: 9.22 Buy
20-day EMA: 9.59 Sell
50-day EMA: 9.72 Sell
200-day EMA: 8.18 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.29 Sell
20-day SMA: 96.26 Sell
50-day SMA: 107.61 Sell
200-day SMA: 124.92 Sell
8-day EMA: 82.75 Sell
20-day EMA: 92.99 Sell
50-day EMA: 104.03 Sell
200-day EMA: 117.97 Sell

Adtran Holdings Earnings Growth & ADTN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.01 per share, an increase this year of $0.55 per share, and an increase next year of $0.26 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.

Adtran Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):